because we ca n't afford the basketball court corcept , which has run a series of studies , demonstrating poor efficacy of its drug corlux mifepristone ru in treating psychotic depression , has watched its chief financial officer resign way to get off the sinking ship fred ! recently corcept also stated in a press release that for the fourth quarter of , corcept reported a net loss of million , or per share , compared to a net loss of million , or per share , for the fourth quarter of for the full year , the company reported a net loss of million , or per share this compares to a net loss of million , or per share , for the full year as of december , , corcept had cash , cash equivalents and marketable securities of million the total cash used in the company 's operating activities for the full year was million commenting on corcept 's financial guidance for , fred kurland , corcept 's chief financial officer , stated , based on the currently planned timeline of our clinical development program and assuming that we are able to raise funds for intended operations , we expect that net cash used in will be between million and million if we are not able to raise additional funds , we will not be able to continue operations beyond the second quarter of sounds like a plea of desperation to me anyone willing to sign up ? i 'll just get my checkbook out now corcept stock incredibly was once valued at over per share , and now sits at cents i guess you could call this an extreme form of value investing except for the company 's lack of earnings it appears that just issuing press releases and or writing journal articles that spin their negative findings as positive is not working so well